[HTML][HTML] BA. 2 and BA. 5 omicron differ immunologically from both BA. 1 omicron and pre-omicron variants

A Rössler, A Netzl, L Knabl, H Schäfer, SH Wilks… - Nature …, 2022 - nature.com
Several studies have shown that SARS-CoV-2 BA.1 omicron is an immune escape variant.
Meanwhile, however, omicron BA.2 and BA.5 became dominant in many countries and …

[HTML][HTML] Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: the pragmatic, multi-center, three …

Z Bánki, J Mateus, A Rössler, H Schäfer, D Bante… - …, 2022 - thelancet.com
Background Several COVID-19 vaccines have been approved. The mRNA vaccine from
Pfizer/BioNTech (Comirnaty, BNT162b2; BNT) and the vector vaccine from AstraZeneca (…

[HTML][HTML] Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label …

…, Z Bánki, J Kimpel, A Rössler, H Schäfer… - The Lancet …, 2023 - thelancet.com
Background Correlates of protection could help to assess the extent to which a person is
protected from SARS-CoV-2 infection after vaccination (so-called breakthrough infection). We …

[HTML][HTML] Six-month follow-up of immune responses after a rapid mass vaccination against SARS-CoV-2 with BNT162b2 in the district of Schwaz/Austria

…, L Seekircher, B Falkensammer, D Bante, H Schäfer… - Viruses, 2022 - mdpi.com
In response to a large outbreak of the SARS-CoV-2 Beta (B.1.351) variant in the district
Schwaz, Austria, a rapid mass vaccination campaign with BNT162b2 was carried out in spring …

[HTML][HTML] Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B. 1.351-variant …

…, J Kimpel, H Winner, T Harthaller, H Schäfer… - Frontiers in Public …, 2022 - frontiersin.org
In order to curb the rapid dissemination of the B.1.351 variant of SARS-CoV-2 in the district
of Schwaz and beyond, the EU allocated additional vaccine doses at the beginning of March …

Immune response to 2-dose BNT162b2 vaccination and risk of SARS-CoV-2 breakthrough infection: The Shieldvacc-2 study

L Seekircher, Z Bánki, J Kimpel, A Rössler, H Schäfer… - medRxiv, 2022 - medrxiv.org
It is uncertain to which extent antibody and T-cell responses after vaccination against SARS-CoV-2
are associated with reduced risk of breakthrough infection and whether their …

[HTML][HTML] High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz

T Harthaller, W Borena, D Bante, H Schäfer… - Viruses, 2022 - mdpi.com
Complementing the adult seroprevalence data collected at the time of the rapid SARS-CoV-2
mass vaccination in the district of Schwaz in 2021, we set out to establish the …

[PDF][PDF] Microdestruction-When Painkillers Hurt: Diclofenac-inactivating laccases produced by modified C. reinhardtii as an effective wastewater treatment option

H Schäfer, Y Schermer, A Hinkle, R Avers - static.igem.org
Diclofenac is a known anti-inflamatory drug and a primary example of the type of micropollutants
which accumulate in wastewater due to overuse, thus contaminating the environment. …

[PDF][PDF] Mother Nature gets a Detox: Laccase as a Solution to Micropollution

A Hinkle, Y Schermer, H Schäfer - static.igem.org
Painkillers, such as Ibuprofen or Diclofenac, are commonly used medication due to their
antiinflammatory and analgesic properties. The advantages of local use in ointments for …

[CITATION][C] Pre mass vaccination prevalence of SARS-CoV-2 infection in the Tyrolian district of Schwaz

W Borena, P Willeit, H Winner, H Schäfer, D Bante… - 2021 - uni-salzburg.elsevierpure.com
… Wegene Borena, Peter Willeit, Hannes Winner, Helena Schäfer, David Bante, Barbara
Falkensammer, Teresa Harthaller, Annika Rössler, Lydia Riepler, Cornelia Ower …